Metlifecare undervalued compared with peers, has scope to rise, Devon’s Glass says

Metlifecare undervalued compared with peers, has scope to rise, Devon’s Glass says
By Tina Morrison Aug. 28 (BusinessDesk) – Metlifecare, New Zealand’s second-largest listed retirement village operator, is undervalued versus its peers Ryman Healthcare and Summerset Group Holdings and has scope to rise, according to a fund manager. Retirement village shares are among the 20 best-performing stocks on New Zealand’s benchmark NZX 50 Index the past year as investors anticipate growth supported by an ageing population. Still, while shares in Ryman have surged 87 percent and Summerset has jumped 67 percent, Metlifecare has grown j...